MedPath

Synergy Effect of the Combination Therapy of Etidronate and Atorvastatin on Atherosclerotic Abdominal Aortic Plaques Detected by Magnetic Resonance Imaging - Open Label Randomized Trial

Phase 4
Conditions
Hyperlipidemia, Diabetes, Hypertension
Registration Number
JPRN-UMIN000002635
Lead Sponsor
iigata-Rousai Hospital
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete: follow-up continuing
Sex
All
Target Recruitment
100
Inclusion Criteria

Not provided

Exclusion Criteria

The patients who have psychic disturbance, Collagen disease, liver renal dysfunction, heart disorder, cerebrovascular disorder, and or serious complications. The patients who were decided that participation is inappropriate for them by chief physician.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
The changing rate (%) of hyperplasia in Maximal Wall Thickness after one year ...ATR + ETD group vs. of ATR group
Secondary Outcome Measures
NameTimeMethod
The changing rate (%) of hyperplasia in Maximal Wall Thickness after one year ...ATR + ETD group vs. of ETD group The changing rate (%) of Total Vascular Area and Lumen Area The changing rate (%) of LDLchol value ...ATR + ETD group vs. ATR group, ATR + ETD group vs. ETD group
© Copyright 2025. All Rights Reserved by MedPath